A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Traumatic Cervical Spinal Cord Injury
Clinical Trial Grant
Administered By
Neurosurgery
Awarded By
AbbVie Inc.
Start Date
December 14, 2020
End Date
October 8, 2025
Administered By
Neurosurgery
Awarded By
AbbVie Inc.
Start Date
December 14, 2020
End Date
October 8, 2025